Xuefeng Shi
- Topics
- Microbial Natural Products and Biosynthesis (4 papers)MicroRNA in disease regulation (3 papers)Liver physiology and pathology (2 papers)
In The Last Decade
Xuefeng Shi
19 papers receiving 344 citations
Peers
Comparison fields: 5 of 79
- Molecular Biology 180
- Cancer Research 103
- Pharmacology 70
- Biotechnology 45
- Organic Chemistry 41
Countries citing papers authored by Xuefeng Shi
This map shows the geographic impact of Xuefeng Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuefeng Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuefeng Shi more than expected).
Fields of papers citing papers by Xuefeng Shi
This network shows the impact of papers produced by Xuefeng Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuefeng Shi. The network helps show where Xuefeng Shi may publish in the future.
Co-authorship network of co-authors of Xuefeng Shi
This figure shows the co-authorship network connecting the top 25 collaborators of Xuefeng Shi. A scholar is included among the top collaborators of Xuefeng Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuefeng Shi. Xuefeng Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 6 | |
| 3 | 2 | |
| 4 | 4 | |
| 5 | 4 | |
| 6 | 4 | |
| 7 | [NK-92 cells modified with chimeric antigen receptor targeting PD-L1 inhibits the proliferation of A549 lung cancer cells]. | 1 |
| 8 | 16 | |
| 9 | 1 | |
| 10 | 16 | |
| 11 | 5 | |
| 12 | 14 | |
| 13 | 20 | |
| 14 | 34 | |
| 15 | 22 | |
| 16 | 36 | |
| 17 | 34 | |
| 18 | 47 | |
| 19 | 74 | |
| 20 | 4 |
About Xuefeng Shi
Xuefeng Shi is a scholar working on Applied Microbiology and Biotechnology, Cancer Research and Geriatrics and Gerontology, having authored 20 papers that have together received 344 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (4 papers), MicroRNA in disease regulation (3 papers) and Liver physiology and pathology (2 papers). The work is most often cited by research in Cancer Research (103 citations), Biotechnology (45 citations) and Pharmacology (70 citations). Xuefeng Shi has collaborated with scholars based in China, Mexico and Germany. Frequent co-authors include Fengjun Xiao, Si Zhang, Yuchan Chen, Weimin Zhang, Fa‐Zuo Wang, Jie Li, Xinpeng Tian, Zhiqun Huang, Lisheng Wang and Chu-Tse Wu. Their work appears in journals such as Scientific Reports, RSC Advances and Frontiers in Psychology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.